KIR3DL1 Antibody (177407) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # FAB12251B
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Biotin
Antibody Source
Monoclonal Mouse IgG2A Clone # 177407
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
BaF3 mouse pro-B cell line transfected with human KIR3DL1
Accession # P43629
Accession # P43629
Specificity
Detects human KIR3DL1 on transfected BaF/3 cells. When tested against a panel of transfectants, no cross-reactivity with KIR2DL1, 2DL2, 2DL3, 2DL4, 2DL5, 2DS1, 2DS2, 2DS4, 3DL2, or 3DS1 is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for KIR3DL1 Antibody (177407) [Biotin]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: KIR3DL1
Long Name
Killer Cell Immunoglobulin-like Receptor, Three Domain Long Cytoplasmic Tail, 1
Alternate Names
CD158e1, Nkat3, NKB1
Gene Symbol
KIR3DL1
Additional KIR3DL1 Products
Product Documents for KIR3DL1 Antibody (177407) [Biotin]
Product Specific Notices for KIR3DL1 Antibody (177407) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...